Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-13

Clinical Trial Update: Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease [NA]

View source ↗

Summary

Pilot open-label study evaluating homocysteine management in levodopa-treated Parkinson's disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oregon Health and Science University | Conditions: Parkinson&Amp;#39;s Disease | NA | Status: RECRUITING